TMFang4apples

Cory Renauer

TMFang4apples’ Activity

Tue Mar 28

CAPS Outperform Pitch

TMFang4apples wrote about Celldex Therapeutics (CLDX) . 6:46 PM

CLDX Outperform

At this price, it's a terrific (highly speculative) bargain.

Caps Pick

TMFang4apples made a pick in CAPS. 6:46 PM

Celldex Therapeutics (CLDX) will Outperform the S&P 500

Wed Mar 22

CAPS Outperform Pitch

TMFang4apples wrote about Intercept Pharmaceuticals (ICPT) . 1:49 PM

ICPT Outperform

A less than ideal safety profile means it could easily succumb to competition further down the road, but Ocaliva is a clear frontrunner for the $30B NASH market. Based on phase 2 results, there's a good chance interim phase 3 data expected in 2019 [more]

Caps Pick

TMFang4apples made a pick in CAPS. 1:49 PM

Intercept Pharmaceuticals (ICPT) will Outperform the S&P 500

Fri Mar 17

Caps Pick

TMFang4apples made a pick in CAPS. 4:30 PM

Omeros (OMER) will Outperform the S&P 500

Tue Mar 7

NL

Article

crenauer published an article 3:29 PM

Celldex Therapeutics, Inc. Is Feeling Some Pressure Today -- Here's Why

With plenty of irons in the fire the biotech stock has a case of the pre-earnings-report jitters.

Sat Mar 4

NL

Article

crenauer published an article 10:34 AM

Here's What Pushed Amarin Corporation plc 15% Higher in February

A less stringent regulatory environment bodes well for Amarin's future.

Fri Mar 3

NL

Article

crenauer published an article 1:59 PM

Here's Why Rite Aid Corporation Staged a 14% Comeback Last Month

Investors appeared more confident that a Walgreens acquisition of Rite Aid will cross antitrust hurdles.

NL

Article

crenauer published an article 10:12 AM

Here's Why Organovo Holdings Inc Dipped 15.7% in February

A bleak forward outlook forced investors to reevaluate their Organovo stock positions.

Thu Mar 2

NL

Article

crenauer published an article 5:26 PM

Here's Why AstraZeneca Plc's Market Value Rose $3.8 Billion in February

With generic competition choking its largest revenue streams, investors still found some reasons to smile.

NL

Article

crenauer published an article 3:34 PM

Here's Why Opko Health Inc. Stock Lost Some More Ground Today

The beleaguered pharmaceutical and diagnostics company's latest earnings report failed to please investors.

CAPS Underperform Pitch

TMFang4apples wrote about Snap Inc. (SNAP) . 2:07 PM

SNAP Underperform

almost $30B for a unprofitable camera company? Please

Caps Pick

TMFang4apples made a pick in CAPS. 2:07 PM

Snap Inc. (SNAP) will Underperform the S&P 500
NL

Article

crenauer published an article 11:27 AM

Glaukos Corp. Stock Notches Gains With Eye-Popping Results

Glaukos reported a banner year for its iStent glaucoma solution and gave investors plenty more to look forward to.

Wed Mar 1

NL

Article

crenauer published an article 3:51 PM

Here's Why Esperion Therapeutics Inc Stock Popped Today

An analyst upgrade in light of President Trump's FDA comments has investors excited again.

NL

Article

crenauer published an article 11:21 AM

Here's Why Neuroderm Ltd Stock Is Surging Today

Some positive clinical-trial results bode well for Neuroderm's Parkinson's treatment technology.

Mon Feb 27

NL

Article

crenauer published an article 5:46 PM

3 Biotech Stocks You Don't Have to Babysit

Find out why Gilead Sciences, Celgene, and Amgen are three of the least stressful biotech stocks you can buy right now.

NL

Article

crenauer published an article 4:36 PM

Here's Why Alnylam Pharmaceuticals, Inc. Stock Bounced Up 10.1% Today

Today was a good day for biotech stocks across the board, including Alnylam Pharmaceuticals.

Sun Feb 26

NL

Article

crenauer published an article 2:13 PM

Better Buy: Bellicum Pharmaceuticals Inc. vs. bluebird bio Inc.

Several of the most interesting drugs in development belong to Bellicum and bluebird bio, but which is the better stock pick right now?

Fri Feb 24

NL

Article

crenauer published an article 3:56 PM

Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics Inc

Celldex and Juno quickly bounced back from high-profile clinical trial failures, but which biotech stock is the better buy right now?

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 56.41
Player Rank 32526 out of 74622
Score 216.86
Score Change Today -2.86
Accuracy 50.00%
Active Picks 7
Total Picks 109
Best Pick NPSP.DL (+169.80)
Worst Pick NSPH (-121.59)
Average Score per Pick 1.99
Charms Earned 3
Highest Rated Favorite TMFBiologyFool
Go to TMFang4apples’ CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFang4apples’ 10 Latest Posts